Monitoring Services

CMX has the proficiency, skill and expertise to monitor your clinical trial. As an established CRO, we have managed and conducted over 60 Phase I to Phase IV trials.

Contact us today to take advantage of our superior monitoring services.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

     

    CMX has also monitored over 75 Bioavailability/Bioequivalent (BA/BE) studies for multiple pharmaceutical companies across the globe.

    Monitoring is conducted effectively and efficiently by trained and certified Clinical Research Associates (CRAs). Our services include Site Qualification Visits (SQVs), Site Initiation Visits (SIVs), Interim Monitoring Visits (IMVs), and Close-Out Visits (COVs) and are coordinated according to the sponsor’s requirements or monitoring plan.

    CMX monitors any medical indication and all phases I-IV including; Urology, Oncology, Immunology, Cardiology, Dermatology, Endocrinology, Respirology, and Medical Devices.

    All studies will be monitored for compliance to ICH GCP. A regulatory overview includes reviewing the Site Master File (SMF) and the essential documents to ensure data integrity.

     
     

    Let CMX Research Inc. plan and implement your Clinical Development Programs. Please fill in the form below or call us at 1-877-290-0018.

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.